<DOC>
	<DOCNO>NCT00882492</DOCNO>
	<brief_summary>This medical research study design see infusion naturally occur hormone , GLP-1 , work use decrease blood sugar cardiac surgery .</brief_summary>
	<brief_title>GLP 1 Intraoperative Glycemic Control</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>1. male female age ( 1880 year ) , 2. ability provide inform consent , 3. elective CABG without single multivalve repair replacement , and/ 4. single multivalve repair replacement require CPB sternotomy ( include subject undergo first time redo cardiac surgery ) . 1. concomitant surgery ( e.g . carotid endarterectomy ) , 2. emergent surgery , 3. current steroid use , 4. insulin dependent diabetes mellitus ( IDDM ) , 5. cardiac surgery without use cardiopulmonary bypass ( e.g . offpump CABG ) , 6. current use positive intravenous inotropic agent , 7. serious intercurrent illness ( endocarditis , sepsis , active malignancy require treatment ) active infection , 8. know substance abuse , 9. receipt investigational drug device within 30 day prior surgery , 10. know allergy follow : GLP1 , fentanyl , midazolam , isoflurane , propofol , morphine , heparin protamine , 11 . Sulfonylurea medication administration morning surgery ( , tolbutamide , tolazamide ( Tolinase ) , chlorpropamide ( Diabinese ) . glipizide ( Glucotrol , Glucotrol XL ) , glyburide ( Micronase , Glynase PresTabs , DiaBeta ) , glimepiride ( Amaryl ) , 12 . Major end organ dysfunction define : 1 . Cardiac : Left ventricular ejection fraction ( LVEF ) &lt; 30 % leave ventriculography echocardiogram ( within 90 day prior randomization ) , current use positive intravenous inotropic agent , preoperative use intraaortic balloon pump ( IABP ) , leave ventricular assist device ( LVAD ) , extracorporeal membrane oxygenation ( ECMO ) ; 2 . Renal : preoperative serum Creatinine &gt; 2.0 mg/dL ; 3 . Hepatic : aspartate aminotransferase ( AST ) alanine transferase ( ALT ) &gt; 2.5 x upper limit normal ; 4 . Hematologic : preoperative hematocrit ( HCT ) &lt; 30 % , platelet count &lt; 100,000/mm3 , history ( family history ) bleed clot disorder ; 13 . Patients history risk factor acute pancreatitis ( i.e . ethanol abuse , gall stone ) exclude study , 14 . Pregnant breastfeeding female , 15. condition , opinion investigator , may compromise safety subject would preclude subject successful completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Cardiac</keyword>
	<keyword>Surgery</keyword>
	<keyword>Glycemia</keyword>
</DOC>